In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
New product reviews for November 2012.

Pharmaceutical Technology
Volume 36, Issue 11, pp. 24

Manufacturing process intelligent software helps improve process predictability



The latest version of Aegis's Discoverant software can perform data aggregation, investigational analytics, and process modeling to improve process predictability and product quality. Discoverant 4.2 includes new features that were developed following input from Aegis customers, such as simplified user management and authentication with network-based group management, enhanced support for global collaboration across multiple time zones, new administrative reports, and greater control over query tools for easier model management. In addition, advanced analysis and data collection are made possible via the software's InVision and PRIMR features.

Aegis Analytical Corp.
http://aegiscorp.com/
Software is available worldwide

Asset management system offers condition-based monitoring capabilities



Honeywell Process Solutions' Asset Manager R410 version offers real-time, condition-based monitoring of equipment to assist in maintenance and reliability planning. The system integrates with IBM's Maximo and SAP enterprise asset management and computerized maintenance management systems. This integration allows maintenance and reliability planners to review the status and priority of equipment health and the severity of any failures, assign resources as well as raise and track work orders directly from Asset Manager. In addition, Honeywell's newest version of its Field Advisor tool, which helps mobile workers prioritize and execute field tasks, has been refreshed to provide efficient automation for rounds and inspections.

Honeywell Process Solutions
http://www.honeywellprocess.com/
System is available worldwide


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
30%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
8%
All of the above.
45%
No government involvement in patient treatment or drug development.
8%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
Source: Pharmaceutical Technology,
Click here